BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15867356)

  • 1. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
    Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
    Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.
    Li H; Myeroff L; Smiraglia D; Romero MF; Pretlow TP; Kasturi L; Lutterbaugh J; Rerko RM; Casey G; Issa JP; Willis J; Willson JK; Plass C; Markowitz SD
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8412-7. PubMed ID: 12829793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer.
    Park JY; Helm JF; Zheng W; Ly QP; Hodul PJ; Centeno BA; Malafa MP
    Pancreas; 2008 May; 36(4):e32-9. PubMed ID: 18437076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
    Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor.
    Park JY; Zheng W; Kim D; Cheng JQ; Kumar N; Ahmad N; Pow-Sang J
    Cancer Detect Prev; 2007; 31(5):359-65. PubMed ID: 18037591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer.
    Ueno M; Toyota M; Akino K; Suzuki H; Kusano M; Satoh A; Mita H; Sasaki Y; Nojima M; Yanagihara K; Hinoda Y; Tokino T; Imai K
    Tumour Biol; 2004; 25(3):134-40. PubMed ID: 15361710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer.
    Park JY; Kim D; Yang M; Park HY; Lee SH; Rincon M; Kreahling J; Plass C; Smiraglia DJ; Tockman MS; Kim SJ
    Lung Cancer; 2013 Mar; 79(3):198-204. PubMed ID: 23273563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties.
    Hubstenberger A; Labourdette G; Baudier J; Rousseau D
    Exp Cell Res; 2008 Sep; 314(15):2870-83. PubMed ID: 18639545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of genetic and epigenetic mechanisms to gene silencing in oligodendrogliomas.
    Hong C; Bollen AW; Costello JF
    Cancer Res; 2003 Nov; 63(22):7600-5. PubMed ID: 14633674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.
    Hernández-Juárez J; Vargas-Sierra O; Herrera LA; Cantú De León D; Fernández-Retana J; Pérez-Plasencia C; López-Camarillo C; Gariglio P; Díaz-Chávez J
    Int J Oncol; 2019 May; 54(5):1613-1624. PubMed ID: 30896789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma.
    Cogdell D; Chung W; Liu Y; McDonald JM; Aldape K; Issa JP; Fuller GN; Zhang W
    Chin J Cancer; 2011 Apr; 30(4):247-53. PubMed ID: 21439246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
    Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
    van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
    Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss.
    Riemenschneider MJ; Reifenberger J; Reifenberger G
    Int J Cancer; 2008 Jun; 122(11):2503-10. PubMed ID: 18302158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
    Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q.
    Li KK; Pang JC; Chung NY; Ng YL; Chan NH; Zhou L; Poon WS; Ng HK
    Int J Cancer; 2007 Feb; 120(4):947-50. PubMed ID: 17187361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional inactivation of TP73 expression in oligodendroglial tumors.
    Dong S; Pang JC; Hu J; Zhou LF; Ng HK
    Int J Cancer; 2002 Mar; 98(3):370-5. PubMed ID: 11920588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
    Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.